Balanced news tone
News Sentiment
SEER sentiment intelligence
Seer Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
50
Balanced news tone
12 relevant articles
Price is moving more forcefully than the current news tone suggests.
81/100 classification confidence.
directly relevant articles
high-authority source matches
+34.0% over one week, +26.2% over four weeks, trend inactive, and near fair-value range.
Seer Inc (SEER) Stock Forum and Discussion
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Earnings
81/100 classification
One-week reaction
34.0%
Price confirming higher
Trend fit
Trend inactive
26.2% over four weeks
Fair value
6.7%
Near fair-value range
Market Dynamics buy signal
Sentiment Mix
Positive, neutral, negative
Positive
1
Neutral
10
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Industry context
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 12:30
- Source
- Market source
Moomoo
Direct company coverage
Seer Inc (SEER) Stock Forum and Discussion
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jul 2026 14:53
- Source
- Moomoo
timothysykes.com
Direct company coverage
Seer Inc. Stock Jumps As CEO Buyout Bid And Activists Collide
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 13:18
- Source
- timothysykes.com
Stock Titan
Direct company coverage
Radoff-JEC seeks Seer board seats (NASDAQ: SEER) in proxy contest
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Seer (NASDAQ: SEER) board rebuffs $2.40 cash offer from Radoff-JEC
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 22 May 2026 07:00
- Source
- Stock Titan
simplywall.st
Industry context
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
simplywall.st
Industry context
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Market source
Industry context
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Market source
Industry context
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
TradingView
Industry context
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView